$IBB Recent News More records for U.S. stocks as Dow

New Post Public Reply Private Reply Replies (0) Message Board

Dec 27, 2014 at 9:35 AM

$IBB Recent News

More records for U.S. stocks as Dow tops 18,000 for first time 4:05 p.m. Dec. 23, 2014 - Anora Mahmudova
Small caps rise within view of uncharted territory 10:26 a.m. Dec. 22, 2014 - Michael Ashbaugh
S&P 500 spikes from major support 11:32 a.m. Dec. 11, 2014 - Michael Ashbaugh
Charting the latest slow-motion breakout attempt 11:22 a.m. Dec. 4, 2014 - Michael Ashbaugh
Strong bull trend reaches uncharted territory 11:51 a.m. Nov. 25, 2014 - Michael Ashbaugh
Strong bull trend reaches uncharted territory 11:29 a.m. Nov. 25, 2014 - Michael Ashbaugh
The trouble with fundamentals 1:38 p.m. Nov. 11, 2014 - The Trading Deck
Charting the S&P 500’s slow-motion breakout 11:00 a.m. Nov. 7, 2014 - Michael Ashbaugh
Amgen's stock drops after trial misses secondary endpoint 9:20 a.m. Nov. 4, 2014 - Tomi Kilgore
S&P, Nasdaq within striking distance of 50-day average 10:22 a.m. Oct. 24, 2014 - Michael Ashbaugh
Broadly-based snapback strengthens bull case 10:10 a.m. Oct. 22, 2014 - Michael Ashbaugh
U.S. stocks jump; Nasdaq enjoys best day in 21 months 3:38 p.m. Oct. 21, 2014 - Anora Mahmudova
U.S. benchmarks hesitate at major resistance 9:26 a.m. Oct. 20, 2014 - Michael Ashbaugh
Charting a failed retest of the 200-day average 10:16 a.m. Oct. 15, 2014 - Michael Ashbaugh
Tekmira CEO says being a biotech is like being in ‘shark-infested water’ 7:03 a.m. Oct. 8, 2014 - Wallace Witkowski
Charting the October technical breakdown 10:06 a.m. Oct. 2, 2014 - Michael Ashbaugh
Charting the S&P 500’s precarious posture 9:44 a.m. Sept. 25, 2014 - Michael Ashbaugh
Nasdaq balks at the September peak 9:40 a.m. Sept. 22, 2014 - Michael Ashbaugh
U.S. stocks end lower; tech and small-caps lead losses 3:09 p.m. Sept. 15, 2014 - Anora Mahmudova
Stock-picking gains traction as volatility looms 5:01 a.m. Sept. 7, 2014 - Wallace Witkowski

Gilead, Abbvie, Express Scripts, And Biotech Industry Turmoil Seen By Market-Makers 9:33 a.m. Dec. 24, 2014 - Seeking Alpha
Why I Expect The Biotech Sell-Off To Continue Into 2015 8:08 a.m. Dec. 24, 2014 - Seeking Alpha
Cramer's Mad Money - Navigator Holdings Has Been Unfairly Punished (12/23/14) 5:37 a.m. Dec. 24, 2014 - Seeking Alpha
Bulls Rejoice Dow 18,000, but Maybe Not for Long 8:51 p.m. Dec. 23, 2014 - InvestorPlace.com
Jim Cramer's 'Mad Money' Recap: Here Are 10 Stocks to Buy on Strong GDP Data 8:26 p.m. Dec. 23, 2014 - TheStreet.com
Investors Should Stay Long Stocks as Market Continues Hitting Highs 3:01 p.m. Dec. 23, 2014 - TheStreet.com
Inside The 2 New Innovative Biotech ETFs From BioShares 3:00 p.m. Dec. 23, 2014 - Seeking Alpha
Gilead Falls on AbbVie and Express Scripts Deal: 3 Biotech ETFs to Watch - ETF News And Commentary 12:02 p.m. Dec. 23, 2014 - Zacks.com
Inside the Two New Innovative Biotech ETFs from BioShares - ETF News And Commentary 8:02 a.m. Dec. 23, 2014 - Zacks.com
Making Money With Charles Payne: 12/22/14 6:00 p.m. Dec. 22, 2014 - FOXBusiness
Abbvie Versus Gilead In Hepatitis C, With Comments On Biotech 2:09 p.m. Dec. 22, 2014 - Seeking Alpha
No Bargains in Rising Market: Why Not Buy High and Sell Higher? 12:29 p.m. Dec. 22, 2014 - TheStreet.com
Bioshares New Equal Weight ETFs Offer Diversification And Growth 11:01 a.m. Dec. 22, 2014 - Seeking Alpha
Trade of the Day: IBB Up 40% YTD – Buy, Sell or Hold? 7:17 p.m. Dec. 21, 2014 - InvestorPlace.com
The Markets Will Sink In Titanic Fashion 9:08 p.m. Dec. 20, 2014 - Seeking Alpha
Juno Therapeutics Debuts on the Nasdaq, Stock Soars 50% 4:31 p.m. Dec. 19, 2014 - TheStreet.com
Steer Clear of Today’s Unusually High-Risk Market 8:42 p.m. Dec. 18, 2014 - InvestorPlace.com
Biogen Idec Poised To Continue Its Stellar Run 12:46 p.m. Dec. 18, 2014 - Seeking Alpha
Look for the S&P 500 to Test This Number 8:46 p.m. Dec. 16, 2014 - InvestorPlace.com
Will the Dow Indices Break Down or Bounce? 8:43 p.m. Dec. 15, 2014 - InvestorPlace.com

GW Pharmaceuticals Added to NASDAQ Biotechnology Index 2:00 a.m. Dec. 22, 2014 - GlobeNewswire
Hyperion Therapeutics Added to Nasdaq Biotechnology Index (NBI) 4:06 p.m. Dec. 18, 2014 - GlobeNewswire
Revance Therapeutics Added to NASDAQ Biotechnology Index 4:06 p.m. Dec. 18, 2014 - GlobeNewswire
Cara Therapeutics Announces Addition to the NASDAQ Biotechnology Index 8:01 a.m. Dec. 18, 2014 - GlobeNewswire
Relypsa to be Added to NASDAQ Biotechnology Index 8:01 a.m. Dec. 17, 2014 - GlobeNewswire
Alder BioPharmaceuticals Announces Addition to NASDAQ Biotechnology Index 4:02 p.m. Dec. 16, 2014 - GlobeNewswire
Kite Pharma Added to the NASDAQ Biotechnology Index 8:01 a.m. Dec. 16, 2014 - GlobeNewswire
Zafgen Added to NASDAQ Biotechnology Index 7:01 a.m. Dec. 16, 2014 - GlobeNewswire
Foundation Medicine to Be Added to NASDAQ Biotechnology Index 6:30 a.m. Dec. 16, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals Added to NASDAQ Biotechnology Index (NBI) 6:30 a.m. Dec. 16, 2014 - BusinessWire - BZX
Cleveland Biolabs; A Diverse Play on Both Biodefense and Cancer 10:51 a.m. Nov. 13, 2014 - ACCESSWIRE
Premier Biomedical Advances Technology via Partnerships 9:29 a.m. May 9, 2014 - ACCESSWIRE
OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture 8:01 a.m. March 10, 2014 - ACCESSWIRE
Regulus Announces Addition to NASDAQ Biotechnology Index 8:00 a.m. Dec. 23, 2013 - PR Newswire
Epizyme, Inc. to Be Added to NASDAQ Biotechnology Index (NBI) and NASDAQ Global Select Market 8:00 a.m. Dec. 20, 2013 - PR Newswire
KYTHERA Biopharmaceuticals Announces Addition to the NASDAQ Biotechnology Index 5:51 p.m. Dec. 19, 2013 - GlobeNewswire
Verastem Announces Addition to the NASDAQ Biotechnology Index 7:00 a.m. Dec. 19, 2013 - BusinessWire
Horizon Pharma to Be Added to NASDAQ Biotechnology Index 7:30 a.m. Dec. 17, 2013 - Marketwire
Chimerix Added to NASDAQ Biotechnology Index (NBI) 7:00 a.m. Dec. 17, 2013 - GlobeNewswire
Annual Changes to the NASDAQ Biotechnology Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Netcapital's 28.62% Plunge: A Fraudulent Drama Unfolds

Netcapital: The Plunge Heard 'Round the Market There it is, clear as day—Netcapital’s (NASDAQ: NCPL) stock plummeting 28.62% like a lead balloon. Shareholders had to watch in horror as pieces of their investments seemed to evaporate, all thanks to a swirl of alleged fraud. You can't just shrug off accusations that a company you've betted on has been cooking its books,...

Veterans, Lawmakers Forge Paths in Spokane Forum

Spokane Forum Sparks Action for Veterans' Policies Gonzaga University turned into a powerhouse of dialogue and determination as the Wounded Warrior Project (WWP) gathered over 145 veterans, elected officials, and advocate groups to hash out critical policy priorities. We're talking high-stakes discussions with real consequences, not just some feel-good meet-up. A...

AI Innovation Incubator Shakes Up Shanghai's Lingang

Incubator Conference Lights Up Lingang Hold onto your hats, folks! Shanghai's Lingang Center is buzzing with activity as the 'World Top-performing Incubator Conference 2026' kicks off. Taking place from October 26 to 28, this gathering isn't just another run-of-the-mill tech meet-up. Oh no, it's about redefining how we talk about innovation, incubation, and the future,...

BETR Faces Shareholder Suit After Plummeting Stock

Better Home & Finance Navigates Turbulent Waters Not every day the news comes up smelling of roses, and that's putting it lightly for Better Home & Finance, trading as NASDAQ: BETR. When you're talking about a splash that sends shockwaves, losing over 28% of your stock value on a single trading day is one whale of a splash indeed. The Numbers That Shook the Waters It's no...

Big Tree Cloud Files Annual Report, Eyes AI Expansion

Annual Reports and Long-Term Vision God, does the stock market love itself some annual filings. Anyway, Big Tree Cloud Holdings Limited (NASDAQ: DSY) just went and did their annual rigmarole with the 20-F form for the fiscal year ending June 2026. Filed with the SEC, they're letting shareholders and the interested masses know—plainly, and probably...

Surgery Partners Buyout: Fair Deal or Insider Jackpot?

What's Going On With Surgery Partners? Alright, here's the scoop that shareholders can't ignore—Surgery Partners (NYSE:SGRY) could be heading under the scalpel itself with a proposed buyout by HealthSpan. For those holding onto SGRY stock, this might feel like watching the rerun of a medical drama where the ending ain't clear yet. Shareholders are set to get $23.50 a...

Abu Dhabi's Youth Orchestra: A Cultural Revolution

A New Dawn for Abu Dhabi's Musical Future Abu Dhabi's making some noise, and I don't mean just any kind of noise. We're talking about a symphony of opportunity. The Department of Culture and Tourism – Abu Dhabi just dropped big news—setting up a dedicated institution for the Youth Orchestra Abu Dhabi. This ain't just a pat on the cultural back; it's a whole new ball...

Pacsun Finds Gear: 177% Sales Surge at F1 Austin!

New Heights in Trackside Fashion Well, it looks like Pacsun's got a knack for making the Austin F1 scene as thrilling as the race itself, weaving fashion into the high-speed atmosphere. This year's Formula 1 United States Grand Prix in Austin brought a whopping 19% sales swell in 2026, marking a total sales increase of 177% since their initial 2023 Austin pop-up. Talk...

ConsensusAI by IDMEXPRESS: A New Era for Course Reviews

Revolutionizing Course Quality Reviews Well, look who decided to shake things up in the world of higher education! IDMEXPRESS has rolled out a tool called ConsensusAI, aimed squarely at transforming how colleges and universities handle course quality reviews. The announcement hit the streets on October 26, 2026, leaving education stakeholders both curious and intrigued....

NOTHING NINE's Global Ambitions: Paris Show's Impact

Paris: Stage or Launchpad? You’d think walking that catwalk in Paris is the holy grail—fashion's own illustrious red carpet. But when you're Chloe, founder of NOTHING NINE, the real hustle kicks off once the lights dim. On 29th September 2026, this designer brand strutted its stuff at one of the grandest venues, Les Invalides, part of the prestigious Paris Fashion...